{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:25:33Z","timestamp":1780586733381,"version":"3.54.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Challenging and still unsolved problems in kidney transplantation are risk stratification and the treatment of humoral rejection. Antibody-mediated rejection is an important cause of early and chronic rejection. The impact of donor-specific HLA antibodies on antibody-mediated rejection\u2013causing graft damage is well known, but the clinical relevance of non-HLA antibodies remains unclear. Recently, in 2 independent studies, a new correlation was found between the presence of non-HLA anti-Rho guanosine diphosphate dissociation inhibitor 2 (ARHGDIB) antibodies and increased graft failure. RhoGDI2, another name for ARHGDIB, is a negative regulator of the Rho guanosine triphosphate (RhoGTP)ases RhoA, Rac1m, and Cdc42, whose main function is regulating the actin network in a variety of cells. RhoGDI2 is mainly expressed intracellularly, and some expression is observed on the cell surface. Currently, there is no mechanism known to explain this correlation. Additionally, the reason why the antibodies are produced is unknown. In this review, we will address these questions, provide an overview of other diseases in which these antibodies are prevalent, and describe the physiological role of RhoGDI2 itself. If the mechanism and impact of RhoGDI2 antibodies in kidney graft failure are known, improved risk stratification can be provided to decrease the rate of donor kidney graft failure.<\/jats:p>","DOI":"10.1097\/txd.0000000000000993","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:40:29Z","timestamp":1586551229000},"page":"e548","source":"Crossref","is-referenced-by-count":12,"title":["A Review on the Function and Regulation of ARHGDIB\/RhoGDI2 Expression Including the Hypothetical Role of ARHGDIB\/RhoGDI2 Autoantibodies in Kidney Transplantation"],"prefix":"10.1097","volume":"6","author":[{"given":"Tineke","family":"Kardol-Hoefnagel","sequence":"first","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie A.L.M.","family":"van Logtestijn","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny G.","family":"Otten","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20231127","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal.","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"R2-20231127","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"key":"R3-20231127","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2016.88","article-title":"The importance of non-HLA antibodies in transplantation.","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R4-20231127","article-title":"Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants.","volume":"449","author":"Terasaki","year":"2003","journal-title":"Clin Transpl"},{"key":"R5-20231127","first-page":"46","article-title":"Antibody-mediated rejection: a review.","volume":"17","author":"Garces","year":"2017","journal-title":"Ochsner J"},{"key":"R6-20231127","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.coi.2008.07.005","article-title":"Relevance of MICA and other non-HLA antibodies in clinical transplantation.","volume":"20","author":"Sumitran-Holgersson","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R7-20231127","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1111\/ajt.15493","article-title":"Antibodies against ARHGDIB are associated with long-term kidney graft loss.","volume":"19","author":"Kamburova","year":"2019","journal-title":"Am J Transplant"},{"key":"R8-20231127","article-title":"Antibodies against ARHGDIB and ARHGDIB gene expression associate with kidney allograft outcome.","author":"Senev","year":"2019","journal-title":"Transplantation"},{"key":"R9-20231127","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10555-012-9376-6","article-title":"The faces and friends of RhoGDI2.","volume":"31","author":"Griner","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"R10-20231127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3892\/ijmm.2014.1765","article-title":"Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.","volume":"34","author":"Yi","year":"2014","journal-title":"Int J Mol Med"},{"key":"R11-20231127","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tcb.2005.05.001","article-title":"GDIs: central regulatory molecules in Rho GTPase activation.","volume":"15","author":"DerMardirossian","year":"2005","journal-title":"Trends Cell Biol"},{"key":"R12-20231127","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0021-9258(18)54000-X","article-title":"GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein.","volume":"268","author":"Chuang","year":"1993","journal-title":"J Biol Chem"},{"key":"R13-20231127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrm3153","article-title":"The \u2018invisible hand\u2019: regulation of RHO GTPases by RHOGDIs.","volume":"12","author":"Garcia-Mata","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R14-20231127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2015.01.005","article-title":"Autoantibodies specific to D4GDI modulate rho gtpase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes.","volume":"58","author":"Barbati","year":"2015","journal-title":"J Autoimmun"},{"key":"R15-20231127","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.90.16.7568","article-title":"Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes.","volume":"90","author":"Scherle","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20231127","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1158\/1078-0432.CCR-03-0653","article-title":"Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.","volume":"10","author":"Theodorescu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R17-20231127","doi-asserted-by":"crossref","first-page":"50121","DOI":"10.1074\/jbc.M204299200","article-title":"Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.","volume":"277","author":"Groysman","year":"2002","journal-title":"J Biol Chem"},{"key":"R18-20231127","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.imbio.2018.07.009","article-title":"Inhibition of RhoA and mTORC2\/Rictor by Fingolimod (FTY720) induces p21-activated kinase 1, PAK-1 and amplifies podosomes in mouse peritoneal macrophages.","volume":"223","author":"Chen","year":"2018","journal-title":"Immunobiology"},{"key":"R19-20231127","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: a key regulator of the cytoskeleton and cell polarity.","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"key":"R20-20231127","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellimm.2015.12.005","article-title":"ROCK inhibition impedes macrophage polarity and functions.","volume":"300","author":"Liu","year":"2016","journal-title":"Cell Immunol"},{"key":"R21-20231127","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0898-6568(98)00063-1","article-title":"Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling.","volume":"11","author":"Olofsson","year":"1999","journal-title":"Cell Signal"},{"key":"R22-20231127","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3892\/mmr.2017.6199","article-title":"Apoptosis-independent cleavage of RhoGDI\u03b2 at Asp19 during PMA-stimulated differentiation of THP-1 cells to macrophages.","volume":"15","author":"Ota","year":"2017","journal-title":"Mol Med Rep"},{"key":"R23-20231127","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.cdd.4400515","article-title":"Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis.","volume":"6","author":"Krieser","year":"1999","journal-title":"Cell Death Differ"},{"key":"R24-20231127","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccell.2016.08.002","article-title":"An osteopontin\/CD44 axis in RhoGDI2-mediated metastasis suppression.","volume":"30","author":"Ahmed","year":"2016","journal-title":"Cancer Cell"},{"key":"R25-20231127","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2321-3868.121646","article-title":"Chronic allograft rejection: a significant hurdle to transplant success.","volume":"2","author":"Kloc","year":"2014","journal-title":"Burns Trauma"},{"key":"R26-20231127","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2019.07.010","article-title":"RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.","volume":"288","author":"Dai","year":"2019","journal-title":"Atherosclerosis"},{"key":"R27-20231127","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCRESAHA.106.145847","article-title":"RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs.","volume":"101","author":"Gorovoy","year":"2007","journal-title":"Circ Res"},{"key":"R28-20231127","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/ars.2019.7798","article-title":"Rho and reactive oxygen species at crossroads of endothelial permeability and inflammation.","volume":"31","author":"Karki","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"R29-20231127","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1074\/mcp.M400165-MCP200","article-title":"Proteomics-based identification of human acute leukemia antigens that induce humoral immune response.","volume":"4","author":"Cui","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"R30-20231127","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/tan.13581","article-title":"Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: a mini-review.","volume":"94","author":"Kamburova","year":"2019","journal-title":"HLA"},{"key":"R32-20231127","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1681\/ASN.2016070756","article-title":"The emerging importance of non-HLA autoantibodies in kidney transplant complications.","volume":"28","author":"Cardinal","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R33-20231127","doi-asserted-by":"crossref","first-page":"318ra200","DOI":"10.1126\/scitranslmed.aac9816","article-title":"The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.","volume":"7","author":"Dieud\u00e9","year":"2015","journal-title":"Sci Transl Med"},{"key":"R34-20231127","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"R35-20231127","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.5604\/17322693.1118217","article-title":"Rho-kinase inhibitor reduces hypersensitivity to ANG II in human mesenteric arteries retrieved and conserved under the same conditions as transplanted organs.","volume":"68","author":"Szadujkis-Szadurski","year":"2014","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"2","key":"R36-20231127","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tips.2005.12.002","article-title":"Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.","volume":"27","author":"Budzyn","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R37-20231127","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1681\/ASN.2007070794","article-title":"Inhibition of renal Rho kinase attenuates ischemia\/reperfusion-induced injury.","volume":"19","author":"Prakash","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R38-20231127","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.transproceed.2009.01.092","article-title":"Interleukin-17 and kidney allograft outcome.","volume":"41","author":"Crispim","year":"2009","journal-title":"Transplant Proc"},{"key":"R39-20231127","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.4049\/jimmunol.0902999","article-title":"Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.","volume":"184","author":"Deteix","year":"2010","journal-title":"J Immunol"},{"key":"R40-20231127","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3904\/kjim.2018.095","article-title":"Clinical significance of Th17 cells in kidney transplantation.","volume":"33","author":"Chung","year":"2018","journal-title":"Korean J Intern Med"},{"key":"R41-20231127","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20231127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4236\/ojots.2012.24012","article-title":"Rock1 inhibitor abrogates chronic rejection in rat cardiac model system.","volume":"2","author":"Zhang","year":"2012","journal-title":"Open J Organ Transplant Surg"},{"key":"R43-20231127","doi-asserted-by":"crossref","first-page":"e0156900","DOI":"10.1371\/journal.pone.0156900","article-title":"Infiltration of macrophages correlates with severity of allograft rejection and outcome in human kidney transplantation.","volume":"11","author":"Bergler","year":"2016","journal-title":"PLoS One"},{"key":"R44-20231127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trim.2018.06.002","article-title":"Screening RhoA\/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.","volume":"50","author":"Chen","year":"2018","journal-title":"Transpl Immunol"},{"key":"R45-20231127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejcb.2010.05.008","article-title":"Podosome regulation by Rho GTPases in myeloid cells.","volume":"90","author":"van Helden","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"R46-20231127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40472-016-0130-9","article-title":"Macrophages as effectors of acute and chronic allograft injury.","volume":"3","author":"Liu","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"R47-20231127","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.healun.2016.08.011","article-title":"Macrophage\/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.","volume":"36","author":"Liu","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R48-20231127","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.transproceed.2018.06.037","article-title":"C3d-binding donor-specific HLA antibody is associated with a high risk of antibody-mediated rejection and graft loss in stable kidney transplant recipients: a single-center cohort study.","volume":"50","author":"Lee","year":"2018","journal-title":"Transplant Proc"},{"key":"R49-20231127","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/08916930600739381","article-title":"Natural antibodies, autoantibodies and complementactivation in tissue injury.","volume":"39","author":"Fleming","year":"2006","journal-title":"Autoimmunity"},{"key":"R50-20231127","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2353\/ajpath.2007.060728","article-title":"Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.","volume":"170","author":"Mahesh","year":"2007","journal-title":"Am J Pathol"},{"key":"R51-20231127","doi-asserted-by":"crossref","first-page":"e0162278","DOI":"10.1371\/journal.pone.0162278","article-title":"The spectrum of renal allograft failure.","volume":"11","author":"Chand","year":"2016","journal-title":"PLoS One"},{"key":"R52-20231127","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.18632\/oncotarget.1733","article-title":"RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.","volume":"5","author":"Cho","year":"2014","journal-title":"Oncotarget"},{"key":"R53-20231127","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.transproceed.2004.12.043","article-title":"Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.","volume":"37","author":"Carter","year":"2005","journal-title":"Transplant Proc"},{"key":"R54-20231127","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R55-20231127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-6143.2005.00690.x","article-title":"Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy.","volume":"5","author":"Joosten","year":"2005","journal-title":"Am J Transplant"},{"key":"R56-20231127","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ajt.12168","article-title":"Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.","volume":"13","author":"Cardinal","year":"2013","journal-title":"Am J Transplant"},{"key":"R57-20231127","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/pmic.201200329","article-title":"Proteomics, transcriptomics and lipidomics of exosomes and ectosomes.","volume":"13","author":"Choi","year":"2013","journal-title":"Proteomics"},{"key":"R58-20231127","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/pr200842h","article-title":"The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.","volume":"11","author":"Choi","year":"2012","journal-title":"J Proteome Res"},{"key":"R59-20231127","first-page":"E21","article-title":"Apoptotic bodies: particular extracellular vesicles involved in intercellular communication.","volume":"9","author":"Battistelli","year":"2020","journal-title":"Biology (Basel)"},{"key":"R60-20231127","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/biosci\/biv084","article-title":"Extracellular vesicles: composition, biological relevance, and methods of study.","volume":"65","author":"Zaborowski","year":"2015","journal-title":"Bioscience"},{"key":"R61-20231127","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.jprot.2011.05.023","article-title":"Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB\/c mice.","volume":"74","author":"Turi\u00e1k","year":"2011","journal-title":"J Proteomics"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000000993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T22:08:22Z","timestamp":1701122902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000993","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]}}}